Cargando…
Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England
BACKGROUND: In patients with type 2 diabetes, hyperglycaemia is an independent risk factor for COVID-19-related mortality. Associations between pre-infection prescription for glucose-lowering drugs and COVID-19-related mortality in people with type 2 diabetes have been postulated but only investigat...
Autores principales: | Khunti, Kamlesh, Knighton, Peter, Zaccardi, Francesco, Bakhai, Chirag, Barron, Emma, Holman, Naomi, Kar, Partha, Meace, Claire, Sattar, Naveed, Sharp, Stephen, Wareham, Nicholas J, Weaver, Andy, Woch, Emilia, Young, Bob, Valabhji, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009618/ https://www.ncbi.nlm.nih.gov/pubmed/33798464 http://dx.doi.org/10.1016/S2213-8587(21)00050-4 |
Ejemplares similares
-
Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study
por: Barron, Emma, et al.
Publicado: (2020) -
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study
por: Holman, Naomi, et al.
Publicado: (2020) -
Associations between reductions in routine care delivery and non-COVID-19-related mortality in people with diabetes in England during the COVID-19 pandemic: a population-based parallel cohort study
por: Valabhji, Jonathan, et al.
Publicado: (2022) -
Care processes in people in remission from type 2 diabetes: A cohort study using the National Diabetes Audit
por: Holman, Naomi, et al.
Publicado: (2022) -
Characteristics and care of young people with type 2 diabetes included in the national diabetes audit datasets for England
por: Misra, Shivani, et al.
Publicado: (2022)